BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16785530)

  • 1. Inhibition of MHC class II expression and immune responses by c-MIR.
    Ohmura-Hoshino M; Matsuki Y; Aoki M; Goto E; Mito M; Uematsu M; Kakiuchi T; Hotta H; Ishido S
    J Immunol; 2006 Jul; 177(1):341-54. PubMed ID: 16785530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines.
    Dolan BP; Phelan TP; Ilkovitch D; Qi L; Wade WF; Laufer TM; Ostrand-Rosenberg S
    J Immunol; 2004 Jan; 172(2):907-14. PubMed ID: 14707062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation.
    Yang H; Qiu Q; Gao B; Kong S; Lin Z; Fang D
    J Exp Med; 2014 Nov; 211(12):2467-79. PubMed ID: 25366967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting edge: requirement of MARCH-I-mediated MHC II ubiquitination for the maintenance of conventional dendritic cells.
    Ohmura-Hoshino M; Matsuki Y; Mito-Yoshida M; Goto E; Aoki-Kawasumi M; Nakayama M; Ohara O; Ishido S
    J Immunol; 2009 Dec; 183(11):6893-7. PubMed ID: 19917682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway.
    Gauvreau ME; Côté MH; Bourgeois-Daigneault MC; Rivard LD; Xiu F; Brunet A; Shaw A; Steimle V; Thibodeau J
    Traffic; 2009 Oct; 10(10):1518-27. PubMed ID: 19566897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity.
    Goto E; Ishido S; Sato Y; Ohgimoto S; Ohgimoto K; Nagano-Fujii M; Hotta H
    J Biol Chem; 2003 Apr; 278(17):14657-68. PubMed ID: 12582153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 10 (IL-10)-mediated Immunosuppression: MARCH-I INDUCTION REGULATES ANTIGEN PRESENTATION BY MACROPHAGES BUT NOT DENDRITIC CELLS.
    Mittal SK; Cho KJ; Ishido S; Roche PA
    J Biol Chem; 2015 Nov; 290(45):27158-27167. PubMed ID: 26408197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
    Hirata S; Senju S; Matsuyoshi H; Fukuma D; Uemura Y; Nishimura Y
    J Immunol; 2005 Feb; 174(4):1888-97. PubMed ID: 15699115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of MHC class I presentation of exogenous antigen by dendritic cells is controlled by CD4+ T cells engaging class II molecules in cholesterol-rich domains.
    Machy P; Serre K; Baillet M; Leserman L
    J Immunol; 2002 Feb; 168(3):1172-80. PubMed ID: 11801652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.
    Cho KJ; Walseng E; Ishido S; Roche PA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10449-54. PubMed ID: 26240324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells.
    Ishikawa R; Kajikawa M; Ishido S
    Int Immunol; 2014 May; 26(5):283-9. PubMed ID: 24370470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG oligodeoxynucleotides down-regulate macrophage class II MHC antigen processing.
    Chu RS; Askew D; Noss EH; Tobian A; Krieg AM; Harding CV
    J Immunol; 1999 Aug; 163(3):1188-94. PubMed ID: 10415013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.
    Shin JS; Ebersold M; Pypaert M; Delamarre L; Hartley A; Mellman I
    Nature; 2006 Nov; 444(7115):115-8. PubMed ID: 17051151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mice expressing MHC class II molecules with truncated A beta cytoplasmic domains reveal signaling-independent defects in antigen presentation.
    Smiley ST; Laufer TM; Lo D; Glimcher LH; Grusby MJ
    Int Immunol; 1995 Apr; 7(4):665-77. PubMed ID: 7547694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of decreasing the affinity of the class II-associated invariant chain peptide on the MHC class II peptide repertoire in the presence or absence of H-2M.
    Honey K; Forbush K; Jensen PE; Rudensky AY
    J Immunol; 2004 Apr; 172(7):4142-50. PubMed ID: 15034026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of dendritic cells in the induction and down-regulation of antigen-specific cutaneous inflammation.
    Krasteva M; Kehren J; Horand F; Akiba H; Choquet G; Ducluzeau MT; Tédone R; Garrigue JL; Kaiserlian D; Nicolas JF
    J Immunol; 1998 Feb; 160(3):1181-90. PubMed ID: 9570532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen-processing mechanisms.
    Askew D; Chu RS; Krieg AM; Harding CV
    J Immunol; 2000 Dec; 165(12):6889-95. PubMed ID: 11120813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and phenotypic evidence for presentation of E alpha 52-68 structurally related self-peptide(s) in I-E alpha-deficient mice.
    Viret C; Janeway CA
    J Immunol; 2000 May; 164(9):4627-34. PubMed ID: 10779766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis.
    Juedes AE; Ruddle NH
    J Immunol; 2001 Apr; 166(8):5168-75. PubMed ID: 11290800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.